322 related articles for article (PubMed ID: 24966974)
21. MicroRNA-142-3p attenuates hepatic ischemia/reperfusion injury via targeting of myristoylated alanine-rich C-kinase substrate.
Li Y; Gao M; Xu LN; Yin LH; Qi Y; Peng JY
Pharmacol Res; 2020 Jun; 156():104783. PubMed ID: 32224251
[TBL] [Abstract][Full Text] [Related]
22. Myricitrin pretreatment ameliorates mouse liver ischemia reperfusion injury.
Shen Y; Shen X; Cheng Y; Liu Y
Int Immunopharmacol; 2020 Dec; 89(Pt A):107005. PubMed ID: 33045574
[TBL] [Abstract][Full Text] [Related]
23. Hydroxysafflor yellow A inhibits IL-1β-induced release of IL-6, IL-8, and MMP-1 via suppression of ERK, NF-κB and AP-1 signaling in SW982 human synovial cells.
Cheng BF; Gao YX; Lian JJ; Guo DD; Wang L; Wang M; Yang HJ; Feng ZW
Food Funct; 2016 Nov; 7(11):4516-4522. PubMed ID: 27713966
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo anti-inflammatory effects of different extracts from Epigynum auritum through down-regulation of NF-κB and MAPK signaling pathways.
Yang M; Wang Y; Patel G; Xue Q; Singor Njateng GS; Cai S; Cheng G; Kai G
J Ethnopharmacol; 2020 Oct; 261():113105. PubMed ID: 32590114
[TBL] [Abstract][Full Text] [Related]
25. Diterpenoid trigonoreidon B isolated from Trigonostemon reidioides alleviates inflammation in models of LPS-stimulated murine macrophages and inflammatory liver injury in mice.
Utaipan T; Suksamrarn A; Kaemchantuek P; Chokchaisiri R; Stremmel W; Chamulitrat W; Chunglok W
Biomed Pharmacother; 2018 May; 101():961-971. PubMed ID: 29635906
[TBL] [Abstract][Full Text] [Related]
26. Tauroursodeoxycholic acid alleviates hepatic ischemia reperfusion injury by suppressing the function of Kupffer cells in mice.
Xu X; Wang M; Li JZ; Wei SD; Wu H; Lai X; Cao D; Ou ZB; Gong J
Biomed Pharmacother; 2018 Oct; 106():1271-1281. PubMed ID: 30119197
[TBL] [Abstract][Full Text] [Related]
27. Hydroxysafflor yellow A protects neuron against hypoxia injury and suppresses inflammatory responses following focal ischemia reperfusion in rats.
Ye SY; Gao WY
Arch Pharm Res; 2008 Aug; 31(8):1010-5. PubMed ID: 18787790
[TBL] [Abstract][Full Text] [Related]
28. Hepatoprotective effects of hydroxysafflor yellow A in D-galactose-treated aging mice.
Min F; Sun H; Wang B; Ahmad N; Guo H; Gao H; Gao Y; Liu X; Li H
Eur J Pharmacol; 2020 Aug; 881():173214. PubMed ID: 32454116
[TBL] [Abstract][Full Text] [Related]
29. Effects of hydroxysafflor yellow A on proliferation and collagen synthesis of rat vascular adventitial fibroblasts induced by angiotensin II.
Yuan W; Yang D; Sun X; Liu W; Wang L; Li X; Man X; Fu Q
Int J Clin Exp Pathol; 2014; 7(9):5772-81. PubMed ID: 25337218
[TBL] [Abstract][Full Text] [Related]
30. Hydroxysafflor Yellow A of Carthamus Tinctorius L., Represses the Malignant Development of Esophageal Cancer Cells via Regulating NF-κB Signaling Pathway.
Chen X; Wang Y; Zhang L; Gao Y
Cell Biochem Biophys; 2020 Dec; 78(4):511-520. PubMed ID: 32705535
[TBL] [Abstract][Full Text] [Related]
31. Neuroprotection of hydroxysafflor yellow A in the transient focal ischemia: inhibition of protein oxidation/nitration, 12/15-lipoxygenase and blood-brain barrier disruption.
Sun L; Yang L; Xu YW; Liang H; Han J; Zhao RJ; Cheng Y
Brain Res; 2012 Sep; 1473():227-35. PubMed ID: 22867942
[TBL] [Abstract][Full Text] [Related]
32. Hydroxysafflor yellow A (HSYA) targets the NF-κB and MAPK pathways and ameliorates the development of osteoarthritis.
Hu ZC; Xie ZJ; Tang Q; Li XB; Fu X; Feng ZH; Xuan JW; Ni WF; Wu AM
Food Funct; 2018 Aug; 9(8):4443-4456. PubMed ID: 30070297
[TBL] [Abstract][Full Text] [Related]
33. Hydroxysafflor yellow A alleviates early inflammatory response of bleomycin-induced mice lung injury.
Wu Y; Wang L; Jin M; Zang BX
Biol Pharm Bull; 2012; 35(4):515-22. PubMed ID: 22466555
[TBL] [Abstract][Full Text] [Related]
34. Protective effect of hydroxysafflor yellow A on dopaminergic neurons against 6-hydroxydopamine, activating anti-apoptotic and anti-neuroinflammatory pathways.
Yang X; Li Y; Chen L; Xu M; Wu J; Zhang P; Nel D; Sun B
Pharm Biol; 2020 Dec; 58(1):686-694. PubMed ID: 32658590
[TBL] [Abstract][Full Text] [Related]
35. HSYA alleviates secondary neuronal death through attenuating oxidative stress, inflammatory response, and neural apoptosis in SD rat spinal cord compression injury.
Pei JP; Fan LH; Nan K; Li J; Dang XQ; Wang KZ
J Neuroinflammation; 2017 May; 14(1):97. PubMed ID: 28468657
[TBL] [Abstract][Full Text] [Related]
36. Hydroxysafflor Yellow A protects spinal cords from ischemia/reperfusion injury in rabbits.
Shan LQ; Ma S; Qiu XC; Zhou Y; Zhang Y; Zheng LH; Ren PC; Wang YC; Fan QY; Ma BA
BMC Neurosci; 2010 Aug; 11():98. PubMed ID: 20707889
[TBL] [Abstract][Full Text] [Related]
37. Synergistic cardioprotective effects of Danshensu and hydroxysafflor yellow A against myocardial ischemia-reperfusion injury are mediated through the Akt/Nrf2/HO-1 pathway.
Hu T; Wei G; Xi M; Yan J; Wu X; Wang Y; Zhu Y; Wang C; Wen A
Int J Mol Med; 2016 Jul; 38(1):83-94. PubMed ID: 27176815
[TBL] [Abstract][Full Text] [Related]
38. Alpinetin protects against hepatic ischemia/reperfusion injury in mice by inhibiting the NF-κB/MAPK signaling pathways.
Pan J; Chen S; Guo W; Cao S; Shi X; Zhang J; Zhang H; Zhang S
Int Immunopharmacol; 2021 Jun; 95():107527. PubMed ID: 33743314
[TBL] [Abstract][Full Text] [Related]
39. Hydroxy-safflor yellow A attenuates Aβ₁₋₄₂-induced inflammation by modulating the JAK2/STAT3/NF-κB pathway.
Zhang ZH; Yu LJ; Hui XC; Wu ZZ; Yin KL; Yang H; Xu Y
Brain Res; 2014 May; 1563():72-80. PubMed ID: 24690200
[TBL] [Abstract][Full Text] [Related]
40. Proteomic Analysis of Hydroxysafflor Yellow A Against Cerebral Ischemia/Reperfusion Injury in Rats.
Xu H; Liu T; Wang W; Su N; Yang L; Yang Z; Dou F; Cui J; Fei F; Ma J; Wen A; Ding Y
Rejuvenation Res; 2019 Dec; 22(6):503-512. PubMed ID: 30712471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
